✦ LIBER ✦

Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial

✍ Scribed by Walid Denguezli; Adnene Trimech; Anis Haddad; Awatef Hajjaji; Zahra Saidani; Raja Faleh; Mohamed Sakouhi

Publisher: Springer
Year: 2007
Tongue: English
Weight: 287 KB
Volume: 276
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-006-0313-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative efficacy and safety of vagin

Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial

✍ Sebiha Özkan; Eray Çalışkan; Emek Doğer; İzzet Yücesoy; Semih Özeren; Birol Vura 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 303 KB

Vaginal misoprostol for cervical priming

Vaginal misoprostol for cervical priming prior to diagnostic hysteroscopy––efficacy, safety and patient satisfaction: a randomized controlled trial

✍ Neeta Singh; Bhaswati Ghosh; Moumita Naha; Suneeta Mittal 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 222 KB

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m